Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Chronic hepatitis B virus (HBV) is a leading cause of liver disease and hepatocellular carcinoma that persists as a DNA mini-chromosome and replicates via genomic RNA intermediates. While HBV replication has been extensively studied, mechanisms governing viral RNA degradation remain unclear. Here, we identify a key role for the 5′–3′ exoribonuclease XRN1 in regulating the HBV transcriptome. Pharmacologic inhibition or genetic ablation of XRN1 increased HBV subgenomic RNAs without affecting pregenomic RNA (pgRNA) levels. Long-read RNA-seq showed that subgenomic RNAs, but not pgRNA, are degraded by XRN1, consistent with differential 5′ cap modification and processing (P-) body localization. HBV infection increased P-body number and size, and delivery of synthetic pgRNA demonstrated that active replication, not RNA expression alone, alters the abundance of P-bodies. These findings identify XRN1 as a key regulator of HBV RNA turnover and uncover a mechanism for viral replication to remodel host RNA dynamics.

More information Original publication

DOI

10.1016/j.isci.2026.116328

Type

Journal article

Publication Date

2026-07-17T00:00:00+00:00

Volume

29